Dr. Glynn Wilson the Chairman and CEO of TapImmune will present at the Sachs Associates' 3rd Annual Bio Partnering & Investment Forum on 2/23. The company had Phase I trials completed with 20 of 21 cancer patients reacting with positive immune responses. Additionally, TapImmune has a very deep drug pipeline in multipe indications for upcoming Phase II trials....
I'm short-term bullish as we come to the end of a bigger descending triangle while testing $340 resistance, which has been tested several times, but there's been a lot of selingl volume lately. Sometime in the next week, I expect the price to react to the new moon and finally break $340 support with conviction and go on to test $300s and possibly down to $250 in...
I see us close to finishing a B wave (which looks like it was a double zig zag) from a larger ABC zig zag up to reach the top of a even larger Wedge. Here are my ideas of where I see us on a larger timeframe: If A=C, we could have a possible high of around 460/470, but I would rather wait to see how the waves (within this C) reveal themselves to get a more...
EURUSD has probably completed correctional phase. As a basic scenario, I will watch for development of another ascending structure for achieving 1.3650.
The recent falls of the BIOTECH sector produce flagrant price variations on a day to hour basis. Correct understanding of the immediate trend can produce significant profits based on available capital for investment and willingness to sell at the appropriate position. Also noted is the long position of this particular opportunity as the company is in the...